Oxford BioDynamics PLC (OBD)

Industry Diagnostics & Research
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

0.25p

Buy

0.26p

arrow-up0.00p (+0.00%)

Prices updated at 12 Dec 2025, 16:42 GMT
| Prices minimum 15 mins delay
|
Prices in GBX
Oxford BioDynamics PLC is a biotechnology company. It is focused on the discovery and development of novel epigenetic biomarkers for use within the pharmaceutical and biotechnology industry.
FTSE All-Share
arrow-down-0.48%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Diagnostics & Research
Chairman
Mr. Iain Gladstone Ross
CEO
-
Most recent earnings
30 Sep 2024
Fiscal year end
30 Sep 2024
Employees
44
Head office
John Smith Drive
Oxford
United Kingdom
OX4 2WB
mobile
+44 1865518910
letter
investorrelations@oxfordbiodynamics.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Dr. David Mark Anthony Holbrook
Non-Executive Director
-
Mr. Peter Eric Presland
Non-Executive Director
-
Mr. Stephen Charles Diggle
Non-Executive Director
-
Dr. Alexandre Akoulitchev
Executive Director, Chief Scientific Officer
-
Mr. Paul Leslie Stockdale
Executive Director, Chief Financial Officer
-
Mr. Iain Gladstone Ross
Executive Director, Chairman
-

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
Unicorn Asset Management Ltd278,464,859
Unicorn AIM VCT Series 3 ORD278,464,859
Chelverton Asset Management Ltd52,620,370
MI Chelverton UK Equity Growth Fund52,620,370
TM Oberon UK Special Situations Fund32,666,667

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
11 Nov 2025Purchase
11 Nov 2025Purchase
11 Nov 2025Purchase
11 Nov 2025Purchase
11 Nov 2025Purchase
10 Apr 2025Purchase
01 Apr 2025Sale
01 Apr 2025Purchase
03 Feb 2025Purchase
03 Feb 2025Purchase
03 Feb 2025Purchase
03 Feb 2025Purchase
16 Jan 2025Purchase
16 Jan 2025Purchase
16 Jan 2025Purchase
16 Jan 2025Purchase
16 Jan 2025Purchase
03 Jan 2025Purchase
31 Dec 2024Transfer in
31 Dec 2024Transfer in
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.